Bleich H E, Freer R J, Stafford S S, Galardy R E
Proc Natl Acad Sci U S A. 1978 Aug;75(8):3630-4. doi: 10.1073/pnas.75.8.3630.
Angiotensin II is known to undergo a reversible conformational transition and a change in potency in rat uterus in vitro with pK approximately 6.5. We have shown by carbon-13 NMR that the conformational transition involves all-trans to partly cis isomerization of the His6-Pro7 peptide bond. Isomerization from all-trans at pH 6.8 to approximately 16% cis at pH 8.0 is therefore correlated with a 10-fold increase in biological activity for [Asp1,Ile5]-angiotensin II in rat uterus in vitro. Isomerization from all-trans at pH 6.8 to approximately 16% cis at pH 8.0 in the competitive inhibitor [Phe4,Tyr8]angiotensin II is correlated with exhibition of virtually no agonist activity at low pH to full agonist activity at high pH. An angiotensin II conformation with Pro7 in the cis form may therefore be the conformation with maximal binding or biological activity at the cellular receptor.
已知血管紧张素II在体外大鼠子宫中会发生可逆的构象转变和效力变化,其pK约为6.5。我们通过碳-13核磁共振显示,构象转变涉及His6-Pro7肽键从全反式到部分顺式的异构化。因此,在体外大鼠子宫中,[Asp1,Ile5]-血管紧张素II从pH 6.8时的全反式异构化为pH 8.0时约16%的顺式,其生物活性增加了10倍。竞争性抑制剂[Phe4,Tyr8]血管紧张素II从pH 6.8时的全反式异构化为pH 8.0时约16%的顺式,与在低pH时几乎无激动剂活性到高pH时完全激动剂活性的表现相关。因此,Pro7为顺式形式的血管紧张素II构象可能是在细胞受体上具有最大结合或生物活性的构象。